371708 Sigma-AldrichGβγ Modulator II, Gallein - CAS 2103-64-2 - Calbiochem
A cell-permeable xanthene compound that binds to Gβγ with high affinity (Kd ~400 nM derived from a surface plasma resonance binding study using Gβ1γ2) and blocks Gβγ-dependent cellular activities.
More>> A cell-permeable xanthene compound that binds to Gβγ with high affinity (Kd ~400 nM derived from a surface plasma resonance binding study using Gβ1γ2) and blocks Gβγ-dependent cellular activities. Less<<Synonyme: 4,5-Dihydroxyfluorescein, dihydrate, 2-(3,4,5-Trihydroxy-6-oxoxanthen-9-yl)-benzoic acid, dihydrate
Empfohlene Produkte
Übersicht
| Replacement Information |
|---|
Key Spec Table
| CAS # | Empirical Formula |
|---|---|
| 2103-64-2 | C₂₀H₁₂O₇ • 2H₂O |
Preis & Verfügbarkeit
| Bestellnummer | Verfügbarkeit | Verpackung | St./Pkg. | Preis | Menge | |
|---|---|---|---|---|---|---|
| 371708-5MG |
|
Kst.-Ampulle | 5 mg |
|
— |
| References | |
|---|---|
| References | Lehmann, D.M., et al. 2008. Mol. Pharmacol. 73, 410. |
| Product Information | |
|---|---|
| CAS number | 2103-64-2 |
| Form | Burgundy solid |
| Hill Formula | C₂₀H₁₂O₇ • 2H₂O |
| Chemical formula | C₂₀H₁₂O₇ • 2H₂O |
| Structure formula Image | |
| Quality Level | MQ100 |
| Applications |
|---|
| Biological Information | |
|---|---|
| Purity | ≥90% by HPLC |
| Physicochemical Information |
|---|
| Dimensions |
|---|
| Materials Information |
|---|
| Toxicological Information |
|---|
| Safety Information according to GHS |
|---|
| Product Usage Statements |
|---|
| Packaging Information | |
|---|---|
| Packaged under inert gas | Packaged under inert gas |
| Transport Information |
|---|
| Supplemental Information |
|---|
| Specifications |
|---|
| Global Trade Item Number | |
|---|---|
| Bestellnummer | GTIN |
| 371708-5MG | 04055977213904 |
Documentation
Gβγ Modulator II, Gallein - CAS 2103-64-2 - Calbiochem SDB
| Titel |
|---|
Gβγ Modulator II, Gallein - CAS 2103-64-2 - Calbiochem Analysenzertifikate
| Titel | Chargennummer |
|---|---|
| 371708 |
Literatur
| Übersicht |
|---|
| Lehmann, D.M., et al. 2008. Mol. Pharmacol. 73, 410. |



